Insider · CIK 0001579179

Brady Todd C

Reports to the SEC for 5 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001579179

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-03	ALDXAldeyra Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+250K sh	$1.67	+$418K	1,721,298
2026-03-27	ALDXAldeyra Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+1.88M sh	—	—	1,880,510
2026-03-27	ALDXAldeyra Therapeutics, Inc. · Bonus UnitsA Award	Director, President and CEO	AAward	+632K sh	—	—	632,318
2025-12-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,218 sh	—	—	0
2025-12-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,187 sh	—	—	0
2025-12-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,833 sh	—	—	0
2025-12-16	EVOKEvoke Pharma IncU Disposition from Tender	Director	UDisposition from Tender	−27 sh	—	—	0
2025-05-21	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+1,187 sh	—	—	8,238
2025-03-04	ALDXAldeyra Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+810K sh	—	—	809,710
2025-01-28	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+5,833 sh	—	—	5,833
2024-05-22	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+14.6K sh	—	—	14,625
2024-03-12	ALDXAldeyra Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−85.3K sh	$3.05	−$260K	1,471,298
2024-03-11	ALDXAldeyra Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−97.9K sh	$3.27	−$321K	1,556,622
2024-03-09	ALDXAldeyra Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+1.08M sh	—	—	1,081,201
2023-09-07	ALDXAldeyra Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+33K sh	$0.55	+$18.2K	1,680,322
2023-09-07	ALDXAldeyra Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+192K sh	$0.55	+$106K	1,647,369
2023-09-07	ALDXAldeyra Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+48K sh	$0.55	+$26.5K	1,728,343
2023-09-07	ALDXAldeyra Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−73.8K sh	$7.22	−$533K	1,654,536
2023-09-07	ALDXAldeyra Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−192K sh	—	—	0
2023-09-07	ALDXAldeyra Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−33K sh	—	—	0
2023-09-07	ALDXAldeyra Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−48K sh	—	—	0
2023-05-10	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+14.6K sh	—	—	14,625
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−15K sh	$7.12	−$107K	0
2023-02-28	ALDXAldeyra Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+250K sh	—	—	250,000
2023-02-28	ALDXAldeyra Therapeutics, Inc.A Award	Director, President and CEO	AAward	+239K sh	—	—	1,455,285
2022-07-15	ALDXAldeyra Therapeutics, Inc. · Bonus UnitsA Award	Director, President and CEO	AAward	+604K sh	—	—	604,308
2022-06-23	ALDXAldeyra Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+17.7K sh	$3.36	+$59.5K	1,216,535
2022-06-17	F-star Therapeutics, Inc.Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2022-04-27	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+57.8K sh	—	—	57,750
2022-03-30	ALDXAldeyra Therapeutics, Inc.A Award	Director, President and CEO	AAward	+250K sh	—	—	1,198,835
2022-03-30	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+250K sh	—	—	250,000
2022-03-30	ALDXAldeyra Therapeutics, Inc. · Bonus UnitsA Award	Director, President and CEO	AAward	+208K sh	—	—	207,758
2021-06-04	F-star Therapeutics, Inc.Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2021-05-05	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+57.8K sh	—	—	57,750
2021-04-12	ALDXAldeyra Therapeutics, Inc.A Award	Director, President and CEO	AAward	+46.6K sh	—	—	948,835
2021-04-12	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+250K sh	—	—	250,000
2020-11-20	F-star Therapeutics, Inc.Stock Option (right to buy)J Other	Director	JOther	−5,500 sh	—	—	0
2020-11-20	F-star Therapeutics, Inc.Stock Option (right to buy)J Other	Director	JOther	−5,500 sh	—	—	0
2020-11-20	F-star Therapeutics, Inc.Warrant (right to buy)J Other	Director	JOther	−11K sh	—	—	0
2020-11-20	F-star Therapeutics, Inc.Stock Option (right to buy)J Other	Director	JOther	−11K sh	—	—	0
2020-11-20	F-star Therapeutics, Inc.Stock Option (right to buy)J Other	Director	JOther	−7,500 sh	—	—	0
2020-11-20	F-star Therapeutics, Inc.Stock Option (right to buy)J Other	Director	JOther	−7,500 sh	—	—	0
2020-11-19	F-star Therapeutics, Inc.WarrantsJ Other	Director	JOther	−2,741 sh	—	—	0
2020-09-30	F-star Therapeutics, Inc.A Award	Director	AAward	+9,235 sh	—	—	60,016
2020-06-30	F-star Therapeutics, Inc.A Award	Director	AAward	+8,418 sh	—	—	50,781
2020-06-24	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-05-27	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+57.8K sh	—	—	57,750
2020-03-31	F-star Therapeutics, Inc.A Award	Director	AAward	+13.3K sh	—	—	42,363

Recent filings

Accepted (ET)
Jun 54
Brady Todd C0001193125-26-259637
SEC(opens sec.gov)
Mar 314
Brady Todd C0001193125-26-134631
SEC(opens sec.gov)
Dec 174
Brady Todd C0001193125-25-322639
SEC(opens sec.gov)
May 224
Brady Todd C0000950170-25-076441
SEC(opens sec.gov)
Mar 64
Brady Todd C0000950170-25-034674
SEC(opens sec.gov)
Jan 294
Brady Todd C0000950170-25-010532
SEC(opens sec.gov)
May 244
Brady Todd C0000950170-24-064687
SEC(opens sec.gov)
Mar 124
Brady Todd C0000950170-24-030309
SEC(opens sec.gov)
Sep 114
Brady Todd C0000950170-23-047530
SEC(opens sec.gov)

Companies

Address

C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE

LEXINGTON, MA, 02421